147 related articles for article (PubMed ID: 3009646)
1. Persistent excretion of cytomegalovirus in heart transplant patients correlates with inversion of the ratio of T helper/T suppressor-cytotoxic cells.
O'Toole CM; Gray JJ; Maher P; Wreghitt TG
J Infect Dis; 1986 Jun; 153(6):1160-2. PubMed ID: 3009646
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset.
Maher P; O'Toole CM; Wreghitt TG; Spiegelhalter DJ; English TA
Clin Exp Immunol; 1985 Dec; 62(3):515-24. PubMed ID: 3002689
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear subsets during cytomegalovirus disease in renal transplant recipients treated with cyclosporine and rabbit antithymocyte globulin.
Metselaar HJ; Rothbarth PH; Wenting GJ; Vaessen LB; Masurel N; Jeekel J; Weimar W
J Med Virol; 1986 May; 19(1):95-100. PubMed ID: 3009707
[TBL] [Abstract][Full Text] [Related]
4. The effect of plasmapheresis and drug immunosuppression on T-cell subsets as defined by monoclonal antibodies.
Kiprov DD; Dau PC; Morand P
J Clin Apher; 1983; 1(2):57-63. PubMed ID: 6152658
[TBL] [Abstract][Full Text] [Related]
5. T lymphocyte subpopulations in congenital cytomegalovirus infection.
Pass RF; Roper MA; August AM
Infect Immun; 1983 Sep; 41(3):1380-2. PubMed ID: 6309670
[TBL] [Abstract][Full Text] [Related]
6. Expression of transferrin receptors on lymphocytes: its correlation with T-helper/T-suppressor cytotoxic ratio and rejection in heart transplant recipients.
Hoshinaga K; Mohanakumar T; Pascoe EA; Szentpetery S; Lee HM; Lower RR
J Heart Transplant; 1988; 7(3):198-204. PubMed ID: 2968444
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte monitoring in kidney transplant recipients undergoing cytomegalovirus infection or rejection episodes.
Fiche M; Soulillou JP; Bignon JD; Billaudel S; Guenel J
Transplantation; 1984 Apr; 37(4):421-3. PubMed ID: 6324426
[No Abstract] [Full Text] [Related]
8. Inflammatory bowel disease: prevalence and level of activation of circulating T-lymphocyte subpopulations mediating suppressor/cytotoxic and helper function as defined by monoclonal antibodies.
Roche JK; Watkins MH; Cook SL
Clin Immunol Immunopathol; 1982 Dec; 25(3):362-73. PubMed ID: 6218946
[No Abstract] [Full Text] [Related]
9. Do anti-T4 (Leu 3) and anti-T8 (Leu 2) monoclonal antibodies delineate T-cell subsets with helper/inducer and suppressor/cytotoxic function, respectively?
Ceuppens J
Thymus; 1983 Sep; 5(5-6):445-6. PubMed ID: 6229066
[No Abstract] [Full Text] [Related]
10. The real meaning of changing peripheral blood helper to cytotoxic/suppressor cell ratio during renal allograft rejection.
Kovithavongs T; Dossetor JB
Transplant Proc; 1984 Dec; 16(6):1486-9. PubMed ID: 6239421
[No Abstract] [Full Text] [Related]
11. [Proliferation of both helper/inducer and suppressor/cytotoxic cells in a case of adult T-cell leukemia].
Hamamatsu C; Hashiba F; Imai S; Natori H; Suzuki A; Takami T; Koizumi S; Iwanaga M; Osato T; Miwa M
Rinsho Ketsueki; 1987 Sep; 28(9):1605-12. PubMed ID: 2893846
[No Abstract] [Full Text] [Related]
12. 'Rejection or infection' predictive value of T-cell subject ratio, before and after heart transplantation.
O'Toole CM; Maher P; Spiegelhalter DJ; Walker JR; Stovin P; Wallwork J; English TA
J Heart Transplant; 1985; 4(5):518-24. PubMed ID: 3039098
[TBL] [Abstract][Full Text] [Related]
13. The possible role of cytotoxic T cells in the mediation of first-set allograft rejection.
Hall BM; Gurley KE; Dorsch SE
Transplantation; 1985 Sep; 40(3):336-9. PubMed ID: 2930923
[No Abstract] [Full Text] [Related]
14. Diurnal variation of lymphocyte subsets identified by monoclonal antibodies.
Bertouch JV; Roberts-Thomson PJ; Bradley J
Br Med J (Clin Res Ed); 1983 Apr; 286(6372):1171-2. PubMed ID: 6220755
[TBL] [Abstract][Full Text] [Related]
15. T-lymphocyte subpopulations and function during murine cytomegalovirus infection.
Sell MS; Bale JF; Giller RH
Pediatr Res; 1985 Jun; 19(6):583-7. PubMed ID: 2989760
[TBL] [Abstract][Full Text] [Related]
16. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
[TBL] [Abstract][Full Text] [Related]
17. T cell subsets in patients with systemic lupus erythematosus.
Kucharz EJ; Sierakowski SJ
Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy for renal transplantation.
Carpenter CB; Strom TB
Springer Semin Immunopathol; 1984; 7(1):43-57. PubMed ID: 6234670
[No Abstract] [Full Text] [Related]
19. Decreased levels of T-cells and cells with suppressor T-cell phenotype as defined by specific monoclonal antibodies in patients with atopic dermatitis.
Faure MR; Gaucherand MA; Thivolet J; Czernielewski JM; Nicolas JF
Clin Exp Dermatol; 1982 Sep; 7(5):513-8. PubMed ID: 6216991
[No Abstract] [Full Text] [Related]
20. Phenotypic analysis of T cell subsets in the blood of chronically aborting women.
Bertotto A; De Felicis Arcangeli C; Zucchetti P; Gerli R; Ferrarese R; Vaccaro R
Clin Exp Obstet Gynecol; 1984; 11(4):147-9. PubMed ID: 6238725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
